Consun Pharmaceutical Group 주식 주식분석 | 주식가격 | 뉴스 | 1681.HK | KYG2524A1031 | A1XAEC

날짜	Consun Pharmaceutical Group 주식 가격
	7.10 undefined
	6.82 undefined
	6.90 undefined
	7.20 undefined
	6.95 undefined
	6.51 undefined
	6.72 undefined
	6.42 undefined
	6.10 undefined
	5.86 undefined
	5.87 undefined
	5.76 undefined
	5.60 undefined
	5.60 undefined
	5.46 undefined
	5.43 undefined
	5.42 undefined
	5.31 undefined

날짜	Consun Pharmaceutical Group 매출	Consun Pharmaceutical Group EBIT	Consun Pharmaceutical Group 이익
2026e	3.86 조. undefined	1.39 조. undefined	1.21 조. undefined
2025e	3.38 조. undefined	1.2 조. undefined	1.05 조. undefined
2024e	2.98 조. undefined	1.01 조. undefined	901.94 백만 undefined
2023	2.59 조. undefined	825.92 백만 undefined	784.53 백만 undefined
2022	2.34 조. undefined	715.41 백만 undefined	682.91 백만 undefined
2021	2.04 조. undefined	660.18 백만 undefined	590.17 백만 undefined
2020	1.75 조. undefined	550.13 백만 undefined	498.79 백만 undefined
2019	1.73 조. undefined	496.38 백만 undefined	79.82 백만 undefined
2018	1.84 조. undefined	655.33 백만 undefined	465.35 백만 undefined
2017	1.66 조. undefined	533.43 백만 undefined	396.24 백만 undefined
2016	1.22 조. undefined	399.39 백만 undefined	307.53 백만 undefined
2015	831.11 백만 undefined	293.93 백만 undefined	249.69 백만 undefined
2014	730.68 백만 undefined	235.46 백만 undefined	211.2 백만 undefined
2013	571.8 백만 undefined	206.8 백만 undefined	152.9 백만 undefined
2012	457.8 백만 undefined	179.2 백만 undefined	136.2 백만 undefined
2011	389.3 백만 undefined	143.6 백만 undefined	107.3 백만 undefined
2010	303.7 백만 undefined	102.3 백만 undefined	79.3 백만 undefined

	매출	EBIT	이익
2010	303.7 백만 CNY	102.3 백만 CNY	79.3 백만 CNY
2011	389.3 백만 CNY	143.6 백만 CNY	107.3 백만 CNY
2012	457.8 백만 CNY	179.2 백만 CNY	136.2 백만 CNY
2013	571.8 백만 CNY	206.8 백만 CNY	152.9 백만 CNY
2014	730.68 백만 CNY	235.46 백만 CNY	211.2 백만 CNY
2015	831.11 백만 CNY	293.93 백만 CNY	249.69 백만 CNY
2016	1.22 조. CNY	399.39 백만 CNY	307.53 백만 CNY
2017	1.66 조. CNY	533.43 백만 CNY	396.24 백만 CNY
2018	1.84 조. CNY	655.33 백만 CNY	465.35 백만 CNY
2019	1.73 조. CNY	496.38 백만 CNY	79.82 백만 CNY
2020	1.75 조. CNY	550.13 백만 CNY	498.79 백만 CNY
2021	2.04 조. CNY	660.18 백만 CNY	590.17 백만 CNY
2022	2.34 조. CNY	715.41 백만 CNY	682.91 백만 CNY
2023	2.59 조. CNY	825.92 백만 CNY	784.53 백만 CNY
2024e	2.98 조. CNY	1.01 조. CNY	901.94 백만 CNY
2025e	3.38 조. CNY	1.2 조. CNY	1.05 조. CNY
2026e	3.86 조. CNY	1.39 조. CNY	1.21 조. CNY

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0.3	0.39	0.46	0.57	0.73	0.83	1.22	1.66	1.84	1.73	1.75	2.04	2.34	2.59	2.98	3.38	3.86
-	28.38	17.48	24.95	27.85	13.84	47.17	35.73	11.02	-6.24	1.39	16.67	14.43	10.73	14.94	13.60	14.02
79.21	75.32	75.71	79.16	78.22	80.63	74.49	73.98	75.09	72.97	75.40	74.71	75.33	74.17	-	-	-
0.24	0.29	0.35	0.45	0.57	0.67	0.91	1.23	1.38	1.26	1.32	1.53	1.76	1.92	0	0	0
0.1	0.14	0.18	0.21	0.24	0.29	0.4	0.53	0.66	0.5	0.55	0.66	0.72	0.83	1.01	1.2	1.39
33.66	36.76	39.17	36.08	32.19	35.26	32.62	32.11	35.54	28.70	31.39	32.29	30.57	31.85	33.99	35.48	36.02
0.08	0.11	0.14	0.15	0.21	0.25	0.31	0.4	0.47	0.08	0.5	0.59	0.68	0.78	0.9	1.05	1.21
-	35.44	27.10	11.76	38.82	18.01	23.29	28.99	17.42	-83.01	530.38	18.47	15.59	14.96	14.92	15.98	15.31
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
750	750	750	758.9	998.52	981.57	959.73	867.11	877.99	854.47	817.26	804.7	792	799.17	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.03	0.06	0.08	0.9	1.09	0.49	0.67	0.99	1.27	1.38	1.94	2.43	3.04	3.58
172.7	215.7	248.5	225	232.14	363.7	557.28	970.29	863.99	763.81	448.54	351.23	259.56	255.84
25.7	7.8	5	7.5	11.53	22.76	9.15	15.78	20.28	28.44	9.89	18.34	36.1	54.13
34.9	20.4	22.4	49	53.48	71.01	140.97	200	210.31	210.68	227.37	243.04	276.08	367.09
6.3	7.2	87.4	9.2	4.8	12.73	9.9	9.02	31.83	23.49	32.62	16.9	11.58	17.82
0.27	0.32	0.45	1.19	1.4	0.96	1.39	2.18	2.4	2.41	2.66	3.06	3.62	4.28
127.2	150.9	171.5	232.3	229.91	223.77	392.88	400.8	561.79	661.31	675.77	724.63	746.21	739.06
2.6	2.6	2.6	2.6	2.6	639.26	21.15	20.48	17.2	16.65	16.12	15.62	21.63	23.86
0	0	0	0	0	0	0	0	0	0	0	18.34	36.1	0
0	0	0	0	0	0	489.63	460.22	430.8	396.07	371.42	341.66	311.9	283.14
0	0	0	0	0	0	320.65	320.65	320.65	0	0	0	0	0
30.7	27.6	26.9	29.4	33.9	94.67	144.74	185.23	170.45	224.41	228.24	224.99	189.97	183.85
0.16	0.18	0.2	0.26	0.27	0.96	1.37	1.39	1.5	1.3	1.29	1.33	1.31	1.23
0.43	0.5	0.65	1.46	1.66	1.92	2.76	3.57	3.9	3.71	3.95	4.38	4.93	5.51

80.8	80.8	0	78.3	78.25	78.07	76.24	68.65	68.78	68.03	64.42	64.8	63.45	63.81
0	0	0	722.6	684.6	647.94	454.13	247.27	187.91	145.4	0	19.79	0	18.15
0.17	0.17	0.36	0.46	0.67	0.91	1.23	1.43	1.9	1.78	2.15	2.56	3.08	3.54
-0.2	-0.2	-0.2	-0.2	0.17	0.21	0.36	0.34	0.35	2.82	1.69	1.85	2.08	1.84
0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.25	0.25	0.36	1.26	1.43	1.64	1.76	1.75	2.16	1.99	2.22	2.65	3.15	3.63
0.03	0.02	0.03	0.02	0.04	0.04	0.08	0.07	0.09	0.06	0.05	0.07	0.06	1.03
41.5	39.7	46.6	59.6	73.29	94.78	237.38	411.73	446.17	364.6	406.42	465.53	566.13	638.76
100.9	165.7	181.8	70	68.54	94.81	229.62	296.14	313.03	322.61	325.14	222.82	270.24	265.51
0	0	0	0	0	0	0	0	0	0	549.41	599.3	450.52	503.42
0	13.6	0	0	0	0	0	193.62	147.2	553.57	0	3.12	3.71	4.22
0.17	0.24	0.26	0.15	0.18	0.23	0.55	0.97	1	1.3	1.33	1.36	1.35	2.44
0	0	0	0	0	0	0	374.48	245.34	0	0	8.55	5.95	3.9
8.1	13.8	28.6	39.9	39.49	40.2	129.67	142.41	137.22	88.29	86.26	69.3	78.01	71.21
2	1.9	1.9	9.6	12.02	11.58	21.6	20.74	18.32	16.74	15.63	16.7	18.93	19.18
10.1	15.7	30.5	49.5	51.51	51.79	151.27	537.64	400.87	105.03	101.89	94.55	102.89	94.29
0.18	0.25	0.29	0.2	0.23	0.28	0.7	1.51	1.4	1.4	1.43	1.45	1.45	2.53
0.43	0.5	0.65	1.46	1.66	1.92	2.46	3.25	3.56	3.4	3.65	4.1	4.6	6.16

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
103	145	179	210	264	314	403	544	616	133	583	695	746
11	10	11	12	15	19	40	67	71	73	71	72	75
0	0	0	0	0	0	0	0	0	0	0	0	0
-47	-98	-62	-55	-4	-164	-15	-368	3	-280	191	-36	165
2	0	0	-4	19	14	21	8	62	456	19	-6	-40
0	0	0	0	0	0	1	24	22	24	21	12	10
8	20	51	43	42	62	62	93	120	160	115	182	13
68	56	128	163	294	184	449	252	754	383	867	725	947
-17	-31	-37	-64	-20	-17	-25	-54	-193	-179	-53	-98	-51
-16	-29	-111	16	-248	-455	91	-60	-180	-110	-25	-298	-368
1	1	-74	80	-227	-438	116	-5	12	69	28	-200	-317
0	0	0	0	0	0	0	0	0	0	0	0	0
0	13	-13	0	0	0	-90	594	-197	147	25	59	-177
0	0	14	852	-45	-53	-81	-261	5	-43	-152	-15	-26
-70	6	0	640	-104	-81	-358	128	-292	-156	-279	-166	-342
-70.00	-7.00	-	-30.00	-21.00	-	-72.00	-31.00	-32.00	-34.00	-21.00	-12.00	-10.00
0	0	0	-181	-38	-28	-114	-173	-68	-225	-131	-198	-127
-18	32	16	820	-58	-353	182	316	280	113	557	256	253
51.2	25	91.5	99.5	273.75	166.76	424.15	197.15	560.86	203.39	813.36	627.29	896.09
0	0	0	0	0	0	0	0	0	0	0	0	0

Consun Pharmaceutical Group 브루토마진	Consun Pharmaceutical Group 이익 마진	Consun Pharmaceutical Group EBIT-마진	Consun Pharmaceutical Group 이익 마진
2026e	74.19 %	36.02 %	31.26 %
2025e	74.19 %	35.48 %	30.91 %
2024e	74.19 %	33.98 %	30.29 %
2023	74.19 %	31.89 %	30.29 %
2022	75.35 %	30.58 %	29.19 %
2021	74.7 %	32.29 %	28.86 %
2020	75.4 %	31.39 %	28.46 %
2019	72.99 %	28.72 %	4.62 %
2018	75.08 %	35.54 %	25.24 %
2017	73.99 %	32.13 %	23.87 %
2016	74.46 %	32.64 %	25.14 %
2015	80.68 %	35.37 %	30.04 %
2014	78.25 %	32.23 %	28.9 %
2013	79.08 %	36.17 %	26.74 %
2012	75.73 %	39.14 %	29.75 %
2011	75.47 %	36.89 %	27.56 %
2010	79.03 %	33.68 %	26.11 %

	브루토마진	EBIT-마진	이익 마진
2010	79.03 %	33.68 %	26.11 %
2011	75.47 %	36.89 %	27.56 %
2012	75.73 %	39.14 %	29.75 %
2013	79.08 %	36.17 %	26.74 %
2014	78.25 %	32.23 %	28.9 %
2015	80.68 %	35.37 %	30.04 %
2016	74.46 %	32.64 %	25.14 %
2017	73.99 %	32.13 %	23.87 %
2018	75.08 %	35.54 %	25.24 %
2019	72.99 %	28.72 %	4.62 %
2020	75.4 %	31.39 %	28.46 %
2021	74.7 %	32.29 %	28.86 %
2022	75.35 %	30.58 %	29.19 %
2023	74.19 %	31.89 %	30.29 %
2024e	74.19 %	33.98 %	30.29 %
2025e	74.19 %	35.48 %	30.91 %
2026e	74.19 %	36.02 %	31.26 %

날짜	Consun Pharmaceutical Group 주당 매출	Consun Pharmaceutical Group EBIT 당 주식	Consun Pharmaceutical Group 주당 이익
2026e	4.67 undefined	0 undefined	1.46 undefined
2025e	4.09 undefined	0 undefined	1.26 undefined
2024e	3.6 undefined	0 undefined	1.09 undefined
2023	3.24 undefined	1.03 undefined	0.98 undefined
2022	2.95 undefined	0.9 undefined	0.86 undefined
2021	2.54 undefined	0.82 undefined	0.73 undefined
2020	2.14 undefined	0.67 undefined	0.61 undefined
2019	2.02 undefined	0.58 undefined	0.09 undefined
2018	2.1 undefined	0.75 undefined	0.53 undefined
2017	1.91 undefined	0.62 undefined	0.46 undefined
2016	1.27 undefined	0.42 undefined	0.32 undefined
2015	0.85 undefined	0.3 undefined	0.25 undefined
2014	0.73 undefined	0.24 undefined	0.21 undefined
2013	0.75 undefined	0.27 undefined	0.2 undefined
2012	0.61 undefined	0.24 undefined	0.18 undefined
2011	0.52 undefined	0.19 undefined	0.14 undefined
2010	0.4 undefined	0.14 undefined	0.11 undefined

	주당 매출	EBIT 당 주식	주당 이익
2010	0.4 CNY	0.14 CNY	0.11 CNY
2011	0.52 CNY	0.19 CNY	0.14 CNY
2012	0.61 CNY	0.24 CNY	0.18 CNY
2013	0.75 CNY	0.27 CNY	0.2 CNY
2014	0.73 CNY	0.24 CNY	0.21 CNY
2015	0.85 CNY	0.3 CNY	0.25 CNY
2016	1.27 CNY	0.42 CNY	0.32 CNY
2017	1.91 CNY	0.62 CNY	0.46 CNY
2018	2.1 CNY	0.75 CNY	0.53 CNY
2019	2.02 CNY	0.58 CNY	0.09 CNY
2020	2.14 CNY	0.67 CNY	0.61 CNY
2021	2.54 CNY	0.82 CNY	0.73 CNY
2022	2.95 CNY	0.9 CNY	0.86 CNY
2023	3.24 CNY	1.03 CNY	0.98 CNY
2024e	3.6 CNY	0 CNY	1.09 CNY
2025e	4.09 CNY	0 CNY	1.26 CNY
2026e	4.67 CNY	0 CNY	1.46 CNY

	주식 수량
2010	750 백만 Aktien
2011	750 백만 Aktien
2012	750 백만 Aktien
2013	758.9 백만 Aktien
2014	998.52 백만 Aktien
2015	981.57 백만 Aktien
2016	959.73 백만 Aktien
2017	867.11 백만 Aktien
2018	877.99 백만 Aktien
2019	854.47 백만 Aktien
2020	817.26 백만 Aktien
2021	804.7 백만 Aktien
2022	792 백만 Aktien
2023	799.17 백만 Aktien
2024e	799.17 백만 Aktien
2025e	799.17 백만 Aktien
2026e	799.17 백만 Aktien

날짜	Consun Pharmaceutical Group 배당금
2026e	0.52 undefined
2025e	0.52 undefined
2024e	0.52 undefined
2023	0.45 undefined
2022	0.2 undefined
2021	0.3 undefined
2020	0.18 undefined
2019	0.3 undefined
2018	0.1 undefined
2017	0.25 undefined
2016	0.14 undefined
2015	0.04 undefined
2014	0.04 undefined

	배당금	배당금 (추정)
2010	0 CNY	0 CNY
2011	0 CNY	0 CNY
2012	0 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0.04 CNY	0 CNY
2015	0.04 CNY	0 CNY
2016	0.14 CNY	0 CNY
2017	0.25 CNY	0 CNY
2018	0.1 CNY	0 CNY
2019	0.3 CNY	0 CNY
2020	0.18 CNY	0 CNY
2021	0.3 CNY	0 CNY
2022	0.2 CNY	0 CNY
2023	0.45 CNY	0 CNY
2024e	0 CNY	0.52 CNY
2025e	0 CNY	0.52 CNY
2026e	0 CNY	0.52 CNY

날짜	Consun Pharmaceutical Group 배당률
2026e	30.56 %
2025e	28.72 %
2024e	31.77 %
2023	31.2 %
2022	23.19 %
2021	40.91 %
2020	29.49 %
2019	321.16 %
2018	18.87 %
2017	53.83 %
2016	44.03 %
2015	13.95 %
2014	17.97 %
2013	31.2 %
2012	31.2 %
2011	31.2 %
2010	31.2 %

	배당률
2010	31.2 %
2011	31.2 %
2012	31.2 %
2013	31.2 %
2014	17.97 %
2015	13.95 %
2016	44.03 %
2017	53.83 %
2018	18.87 %
2019	321.16 %
2020	29.49 %
2021	40.91 %
2022	23.19 %
2023	31.2 %
2024e	31.77 %
2025e	28.72 %
2026e	30.56 %

%-지분	이름	주식	변경
25.13746 %	An (Yubao)	207,737,455	0
2.08796 %	The Vanguard Group, Inc.	17,254,994	-158,000
16.47421 %	Li (Quan)	136,143,899	0
13.31670 %	Young (Wai Po)	110,050,000	0
1.75834 %	An (Meng)	14,531,000	0
1.09244 %	Dimensional Fund Advisors, L.P.	9,028,000	0
0.79471 %	Fidelity Management & Research Company LLC	6,567,534	-9,938
0.51364 %	Norges Bank Investment Management (NBIM)	4,244,783	-4,845,499
0.37355 %	AllianceBernstein L.P.	3,087,000	0
0.21890 %	California State Teachers Retirement System	1,809,000	-809,000
0.16531 %	Fidelity Investments Canada ULC	1,366,153	5,258
0.12185 %	Thrivent Asset Management, LLC	1,007,000	0
0.09596 %	Union Investment Luxembourg S.A.	793,000	0
0.08846 %	Fullgoal Fund Management Co., Ltd.	731,000	0
0.08362 %	Bellevue Asset Management AG	691,000	191,000
0.07563 %	AXA Investment Managers UK Ltd.	625,000	0
0.07079 %	Dimensional Fund Advisors, Ltd.	585,000	0
0.06612 %	State Street Global Advisors (US)	546,400	-50,000
0.06494 %	Florida State Board of Administration	536,660	-514,800
0.04483 %	Segall Bryant & Hamill, LLC	370,492	0
0.04284 %	Schroder Investment Management Ltd. (SIM)	354,000	0
0.04017 %	China Asset Management (Hong Kong) Limited	332,000	332,000
0.03485 %	Nuveen LLC	288,000	0
0.03376 %	Chou Associates Management Inc.	279,000	0
0.03328 %	1741 Fund Solutions AG	275,000	0
0.02686 %	BlackRock Institutional Trust Company, N.A.	222,000	46,000
0.02521 %	Fidelity Institutional Asset Management	208,329	-5,938,411
0.02335 %	Signal Iduna Asset Management GmbH	193,000	0
0.01960 %	Acadian Asset Management LLC	162,000	0
0.01936 %	BlackRock Advisors (UK) Limited	160,000	1,000
0.01863 %	Goldman Sachs Asset Management, L.P.	154,000	0
0.01830 %	DFA Australia Ltd.	151,217	41,217
0.01658 %	American Century Investment Management, Inc.	137,000	0
0.01214 %	Prudential Capital Group	100,300	3,000
0.00811 %	Vanguard Global Advisers LLC	67,000	21,000
0.00799 %	State Street Global Advisors Ireland Limited	66,000	0
0.00762 %	Finlabo SIM S.p. A.	63,000	0
0.00605 %	Russell Investments Limited	50,000	0
0.00477 %	Vanguard Investments Australia Ltd.	39,440	70
0.00206 %	Legal & General Investment Management Ltd.	17,000	0
0.00073 %	Connor, Clark & Lunn Investment Management Ltd.	6,000	0
0 %	RAM Active Investments S.A.	0	-55,000
0 %	Axiom Investors	0	-19,000
0 %	Eurizon Capital SGR S.p.A.	0	-100,300
0 %	Irish Life Investment Managers Ltd.	0	-83,447
0 %	Schroder Investment Management North America Inc.	0	-1,087,000
0 %	Grantham Mayo Van Otterloo & Co LLC	0	-27,000
0 %	Mellon Investments Corporation	0	-5,800,000

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Alibaba Group Holding	공급업체고객	0,86	-0,59	-0,04	-0,20	0,63	-0,31
JD com A	공급업체고객	0,81	0,12	-0,03	-0,29	-0,15	-

What values and corporate philosophy does Consun Pharmaceutical Group represent?

Consun Pharmaceutical Group Ltd represents values of innovation, integrity, and excellence, as well as a strong commitment to quality healthcare. The company's corporate philosophy focuses on meeting the healthcare needs of individuals and communities by providing safe and effective pharmaceutical products. Consun Pharmaceutical Group Ltd emphasizes research and development, constantly striving to introduce new and improved treatments to enhance people's wellbeing. By maintaining the highest standards of ethical conduct and social responsibility, Consun Pharmaceutical Group Ltd has become a trusted name in the industry. With its dedication to delivering top-quality healthcare solutions, the company aims to improve the quality of life for patients worldwide.

In which countries and regions is Consun Pharmaceutical Group primarily present?

Consun Pharmaceutical Group Ltd is primarily present in China, where it is based. As a leading pharmaceutical company, Consun focuses on research, development, manufacturing, and sales of innovative medicines and healthcare products. With a strong presence in the Chinese market, Consun has established a wide distribution network across various regions within China. The company's commitment to delivering high-quality healthcare solutions has contributed to its success and growth within the Chinese pharmaceutical industry.

What significant milestones has the company Consun Pharmaceutical Group achieved?

Consun Pharmaceutical Group Ltd has achieved several significant milestones. The company successfully obtained Good Manufacturing Practice (GMP) certification, indicating its adherence to quality standards. It has also expanded its product portfolio and established strong market presence in both domestic and international markets. Consun Pharmaceutical Group Ltd has consistently reported steady revenue growth and secured strategic partnerships with leading pharmaceutical companies. Additionally, the company has invested in research and development, leading to the launch of innovative and high-quality pharmaceutical products. Through its commitment to excellence and continuous growth, Consun Pharmaceutical Group Ltd has positioned itself as a reputable player in the pharmaceutical industry.

What is the history and background of the company Consun Pharmaceutical Group?

Consun Pharmaceutical Group Ltd is a renowned pharmaceutical company with a rich history and background. Founded in 1983, the company has grown to become a leading provider of high-quality and innovative healthcare solutions. Consun Pharmaceutical Group Ltd has established itself as a trusted name in the industry, focusing on research, development, production, and marketing of traditional Chinese medicines, chemical drugs, biologics, and other pharmaceutical products. With a commitment to excellence, the company has achieved significant milestones in the field of pharmaceuticals, catering to the healthcare needs of people worldwide. Consun Pharmaceutical Group Ltd's dedication to innovation and quality makes it a reliable player in the global pharmaceutical market.

Who are the main competitors of Consun Pharmaceutical Group in the market?

The main competitors of Consun Pharmaceutical Group Ltd in the market include Pfizer Inc., Johnson & Johnson, Novartis AG, and Roche Holding AG.

In which industries is Consun Pharmaceutical Group primarily active?

Consun Pharmaceutical Group Ltd is primarily active in the pharmaceutical industry. With a focus on research, development, manufacturing, and marketing of pharmaceutical products, Consun Pharmaceutical Group Ltd operates within the healthcare sector. This Chinese company specializes in producing and distributing both modern Western medicines and traditional Chinese medicines. Consun Pharmaceutical Group Ltd aims to provide high-quality and affordable healthcare solutions to the global market.

What is the business model of Consun Pharmaceutical Group?

Consun Pharmaceutical Group Ltd is a leading pharmaceutical company, specializing in the research, development, production, and sale of modern Chinese medicines. The core of their business model lies in integrating traditional Chinese medicine with advanced pharmaceutical technologies. Consun Pharmaceutical Group Ltd focuses on the production and distribution of prescription drugs, over-the-counter drugs, and healthcare products. By leveraging their strong research and development capabilities, they strive to deliver high-quality pharmaceutical products that cater to the healthcare needs of individuals. With a customer-centric approach, Consun Pharmaceutical Group Ltd continues to enhance their product offerings while maintaining their commitment to improving the overall well-being of the community.

Consun Pharmaceutical Group 2024의 P/E 비율은 얼마입니까?

Consun Pharmaceutical Group의 P/E 비율은 6.29입니다.

Consun Pharmaceutical Group 2024의 KUV는 얼마입니까?

Consun Pharmaceutical Group의 P/S 비율은 1.91입니다.

Consun Pharmaceutical Group의 AlleAktien 품질 점수는 얼마인가요?

Consun Pharmaceutical Group에 대한 AlleAktien 품질 점수는 10/10입니다.

Consun Pharmaceutical Group 2024의 매출은 얼마인가요?

예상되는 Consun Pharmaceutical Group 매출은 2.98 조. CNY입니다.

Consun Pharmaceutical Group 2024의 이익은 얼마인가요?

예상되는 Consun Pharmaceutical Group 이익은 901.94 백만 CNY입니다.

Consun Pharmaceutical Group은 무엇을 하나요?

The Consun Pharmaceutical Group Ltd is a Chinese company specializing in the manufacturing and sale of pharmaceutical products, as well as the development of medical technologies. The company operates in three main divisions: Pharmaceuticals, Medical Devices, and Health Services. The Pharmaceuticals division includes the production and sale of pharmaceutical products, including prescription drugs, over-the-counter medications, and health products. The company produces a wide range of medicines, including drugs for the treatment of cardiovascular diseases, diabetes, cancer, infectious diseases, and other conditions. Additionally, Consun also offers alternative medicine products based on oriental healing methods and natural ingredients. The second division, Medical Devices, produces and sells medical equipment and devices such as ultrasound machines, X-ray machines, CT scanners, and other medical instruments. The company has a strong presence in the Chinese market and is striving for further international expansion. Finally, Consun offers health services, including health and wellness programs, medical examinations and diagnostics, hospital administration, and pharmaceutical research and development. There is a network of health centers and clinics throughout China that provide consultations, examinations, and treatments. In terms of research and development, Consun is constantly working to develop innovative technologies and therapies, particularly in the field of cancer drugs and personalized medicine. The company has a strong and growing presence in the international research and development sector and actively collaborates with various institutions and universities. In summary, Consun Pharmaceutical Group Ltd offers a wide range of products and services in the healthcare field, including pharmaceutical products, medical devices, and health services. The company has a strong presence in the Chinese market and is striving for further international expansion. Finally, Consun aims to be innovative and develop new technologies and therapies.

Consun Pharmaceutical Group 배당금은 얼마입니까?

Consun Pharmaceutical Group은(는) 연간 번의 배당을 통해 0.2 CNY의 배당금을 지급합니다.

Consun Pharmaceutical Group이 얼마나 자주 배당을 지급하나요?

Consun Pharmaceutical Group의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Consun Pharmaceutical Group ISIN이 무엇입니까?

Consun Pharmaceutical Group의 ISIN은 KYG2524A1031입니다.

Consun Pharmaceutical Group WKN은 무엇인가요?

Consun Pharmaceutical Group의 WKN은 A1XAEC입니다.

Consun Pharmaceutical Group 티커는 무엇인가요?

Consun Pharmaceutical Group의 티커는 1681.HK입니다.

Consun Pharmaceutical Group이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Consun Pharmaceutical Group은(는) 0.45 CNY 의 배당금을 지급했습니다. 이는 약 6.33 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Consun Pharmaceutical Group은(는) 0.52 CNY의 배당금을 지급할 것으로 예상됩니다.

Consun Pharmaceutical Group의 배당 수익률은 얼마입니까?

Consun Pharmaceutical Group의 현재 배당 수익률은 6.33 %입니다.

Consun Pharmaceutical Group의 배당금은 언제 지급되나요?

Consun Pharmaceutical Group은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Consun Pharmaceutical Group의 배당금은 얼마나 안전한가요?

Consun Pharmaceutical Group은(는) 지난 13년 동안 매년 배당금을 지급했습니다.

Consun Pharmaceutical Group의 배당금은 얼마입니까?

향후 12개월 동안 0.52 CNY의 배당금이 예상됩니다. 이는 배당수익률 7.32 %에 해당합니다.

Consun Pharmaceutical Group이(가) 속해 있는 섹터는 어디인가요?

Consun Pharmaceutical Group은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Consun Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

Consun Pharmaceutical Group의 마지막 배당금을 0.3 CNY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Consun Pharmaceutical Group의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Consun Pharmaceutical Group의 2023년도 배당금은 얼마였습니까?

2023년에 Consun Pharmaceutical Group는 0.2 CNY를 배당금으로 지급했습니다.

Consun Pharmaceutical Group는 어떤 화폐로 배당금을 지급하나요?

Consun Pharmaceutical Group의 배당금은 CNY에 지급됩니다.

증권거래소	Consun Pharmaceutical Group 티커
프랑크푸르트	C1P.F
HKSE	1681.HK

Consun Pharmaceutical Group 티커	Consun Pharmaceutical Group FIGI
1681:HK	BBG005P67Y41
C1P:GR	BBG005SV02V0
C1P:GF	BBG005SV02W9
1681N:L3	BBG00JRFGWB5
1681N:B3	BBG00JRFNC49
1681N:PO	BBG00JRFTWP6
1681HKD:X2	BBG00JRGJNL9
1681HKD:XB	BBG00JRGJNM8
1681HKD:XH	BBG00JRGJNP5
1681HKD:XF	BBG00JRGJNR3
1681HKD:XE	BBG00JRGJNT1
1681HKD:XJ	BBG00JRGJNV8
1681HKD:XL	BBG00JRGJNW7
1681HKD:XG	BBG00JRGJNX6
1681HKD:XO	BBG00JRGJNY5
1681HKD:XS	BBG00JRGJP25
1681HKD:XA	BBG00JRGJP34
1681HKD:E1	BBG00JRGJP43
1681HKD:XT	BBG00JRGJP52
1681HKD:XW	BBG00JRGJP61
1681HKD:XU	BBG00JRGJP70
1681HKD:XV	BBG00JRGJP89
1681HKD:XM	BBG00JRGJP98
1681HKD:XQ	BBG00JRGJPC4
1681HKD:XX	BBG00JRGJPD3
1681HKD:XZ	BBG00JRGJPF1
1681HKD:EU	BBG00JRGJPH9
1681:H2	BBG00K7ZD7B8
1681N:L1	BBG00Y7B13T4
CPHGF:US	BBG00YR11WN6
CPHGF:PQ	BBG00YR11X36
CPHGF:UV	BBG00YR11X45

한 눈에 저평가된 주식을 인식하세요 fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

가격

가격

티커1681.HK

ISINKYG2524A1031

WKNA1XAEC

Consun Pharmaceutical Group 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Consun Pharmaceutical Group 주가 이력

Consun Pharmaceutical Group 주식 매출, EBIT, 이익 KYG2524A1031 · A1XAEC

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Consun Pharmaceutical Group 매출, 이익 및 EBIT 역사

Consun Pharmaceutical Group 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Consun Pharmaceutical Group 주식 마진 KYG2524A1031 · A1XAEC

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Consun Pharmaceutical Group 마진 역사

Consun Pharmaceutical Group 주식 매출, EBIT, 주당 순이익 KYG2524A1031 · A1XAEC

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Consun Pharmaceutical Group 매출, 이익 및 EBIT 주당 역사

Consun Pharmaceutical Group 주식 및 주식 분석

Consun Pharmaceutical Group Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Consun Pharmaceutical Group 역사적인 P/E, EBIT 및 P/S에 따른 평가

Consun Pharmaceutical Group 주식 수량 KYG2524A1031 · A1XAEC

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Consun Pharmaceutical Group 주식 배당금 KYG2524A1031 · A1XAEC

배당금

배당금에 대한 개요

해석 및 사용

투자 전략

Consun Pharmaceutical Group 배당금 내역

Consun Pharmaceutical Group 주식 배당률 KYG2524A1031 · A1XAEC

배당비율

연간 배당비율이란 무엇인가요?

데이터 해석 방법

투자에 대한 데이터 사용

Consun Pharmaceutical Group 배당금지급률 역사

Consun Pharmaceutical Group 수익 예상

한 눈에 저평가된 주식을 인식하세요
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

티커
1681.HK

ISIN
KYG2524A1031

WKN
A1XAEC